Oligonucleotides: Global Markets
Report Scope:
This report covers the worldwide market for oligonucleotide synthesis, which consists of four main product types: oligonucleotide drugs, synthesized oligos, equipment and reagents, and services. Based on application, the market for oligonucleotide synthesis is divided into research and diagnostics and therapeutics.
By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2022 as the base year, with forecasts for 2023 through 2028.
The report also covers approved drugs, the oligonucleotide synthesis process, innovative research, opportunities within the market and profiles of leading companies in the oligonucleotide synthesis industry.
Report Includes:
31 data tables and 48 additional tables
Overview and an analysis of the global markets for oligonucleotides
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
A discussion of the current and future market potential of oligonucleotide synthesis, as well as the competitive landscape, market dynamics, ongoing research, and trends in market growth
Estimate of the market size and revenue forecasts, and a corresponding market share analysis based on product type, application and region
Coverage of the total market for oligonucleotide synthesis, which includes RNA oligos, DNA oligos, and the platform services offered by many companies
Overview of the sustainability trends and ESG developments, with an emphasis on consumer attitudes, ESG score analysis, and the ESG practices followed by leading companies
A look at the recent developments in the market and emerging technologies
An analysis of the key patents and recent clinical trials on oligonucleotide synthesis-based products and applications
Competitive intelligence, including the major vendors’ market shares, recent M&A activity, and venture funding outlook
Profiles of the leading global players, including Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Integrated DNA Technologies, Inc., Eurofins Scientific, and Biolytic Lab Performance Inc.AGILENT TECHNOLOGIES INC.
BIOLEGIO B.V.
BIOLYTIC LAB PERFORMANCE INC.
EUROFINS SCIENTIFIC
GENSCRIPT
INTEGRATED DNA TECHNOLOGIES INC.
LC SCIENCES
LGC GROUP
MERCK KGAA
MICROSYNTH AG
THERMO FISHER SCIENTIFIC INC.
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Insights
- Chapter 2 Market Overview
- Definitions
- History of Oligonucleotide Synthesis
- First Dinucleotide
- Solid Phase Synthesis
- Types of Oligonucleotides
- DNA Probes
- RNA Probes
- Oligonucleotide Synthesis Processes
- Solid Phase Chemical Synthesis
- Alternative Forms of Oligonucleotide Synthesis
- Versatile Functions of Synthetic Oligonucleotides
- Regulatory Paths for Oligotherapeutics
- Animal Models and Studies
- Role of Regulatory Authorities
- Chapter 3 Market Dynamics
- Drivers
- Increasing Use of Synthesized Oligos in Therapeutic Applications
- Rising Government Investments for Synthetic Biology and Genome Projects
- Growing Focus on Personalized Medicine
- Restraints
- Complexities Associated with Oligos
- Lack of Clear Regulatory Infrastructure
- Opportunities
- Expansion of Companies
- Emerging Applications in Various Fields
- Chapter 4 Emerging Technologies and Developments
- Overview
- DNA Synthesizers
- Emerging Technologies
- Microfluidics Approach
- Enzymatic De Novo DNA Synthesis
- Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for Oligonucleotide Synthesis, by Product Type
- Oligonucleotide Drugs
- Equipment and Reagents
- Synthesized Oligos
- Services
- Global Market for Oligonucleotide Synthesis, by Application
- Research
- Diagnostics and Therapeutics
- Geographic Breakdown
- Global Market for Oligonucleotide Synthesis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 6 Competitive Intelligence
- Competitive Landscape
- Patent Analysis
- M&A Analysis
- Funding Outlook
- Industry Structure
- Chapter 7 ESG Development
- Introduction to ESG
- Assessing the Sustainability of the Oligonucleotide Manufacturing Process
- Assessment Against the 12 Principles of Green Chemistry
- Process Mass Intensity (PMI) Assessment
- Assessment of Compounds Used in Oligonucleotide Manufacture
- ESG Performance in Market
- Concluding Remarks from BCC
- Chapter 8 Appendix
- Methodology
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BIOLEGIO B.V.
- BIOLYTIC LAB PERFORMANCE INC.
- EUROFINS SCIENTIFIC
- GENSCRIPT
- INTEGRATED DNA TECHNOLOGIES INC.
- LC SCIENCES
- LGC GROUP
- MERCK KGAA
- MICROSYNTH AG
- THERMO FISHER SCIENTIFIC INC.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook